ICD-10-CM Billable Code

C25.1

Malignant neoplasm of body of pancreas

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the body of the pancreas, classified under ICD-10 code C25.1, is a type of pancreatic cancer that originates in the body region of the pancreas. The pancreas is a vital organ situated behind the stomach, playing an essential role in digestion and blood sugar regulation. When cancer develops in this area, it can affect both its exocrine functions (digestive enzyme production) and endocrine functions (insulin and glucagon production). Due to its often subtle symptoms and late detection, pancreatic cancer, including cancers of the body, generally presents significant treatment challenges. Understanding the nature, causes, and symptoms of this condition can promote earlier diagnosis and better management outcomes.

Causes & Symptoms

Clinical Causes: Genetic mutations which lead to abnormal cell growth in the pancreatic tissue. Hereditary conditions such as hereditary pancreatitis, familial pancreatic cancer, or genetic syndromes like Lynch syndrome. Lifestyle factors including smoking, heavy alcohol consumption, and chronic pancreatitis. Obesity and diabetes mellitus, which may increase the risk of pancreatic tumors. Environmental exposures, such as chemicals or toxins encountered in certain occupations.

Key Symptoms: Jaundice (yellowing of the skin and eyes). Abdominal pain that may radiate to the back. Unintended weight loss and loss of appetite. Digestive issues like nausea, vomiting, or indigestion. New-onset diabetes or worsening control of existing diabetes. Changes in stool, such as pale or greasy stools. Swelling or a palpable mass in the abdomen.

Diagnostic & Treatment

Diagnosis Path: Imaging techniques such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and endoscopic ultrasound (EUS) to visualize the tumor. Laboratory tests including blood work to check for elevated tumor markers like CA 19-9. Biopsy procedures, often guided by imaging, to obtain tissue samples for histopathological confirmation. Laparoscopy or exploratory surgery to assess the extent of disease spread when necessary.

Treatment Protocols: Surgical resection, such as a distal pancreatectomy, to remove the tumor if it is localized and resectable. Chemotherapy regimens aimed at reducing tumor size, controlling spread, and relieving symptoms. Radiation therapy to target cancer cells and shrink tumors. Supportive care to manage symptoms and improve quality of life, including pain management and nutritional support. Emerging targeted therapies and clinical trials exploring novel treatment approaches.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C25.1 a billable ICD-10 code?
Yes, C25.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C25.1?
Clinical documentation must specify the nature of Malignant neoplasm of body of pancreas and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

neoplasm malignant pancreas